Danijela Dukovski

Danijela Dukovski has extensive work experience in the field of biology and therapeutics. Danijela is currently the Director of Cell Biology at Aliada Therapeutics, starting in April 2023. Prior to this, they worked at Vesalius Therapeutics as the Director of Discovery Biology from March 2022 onwards, and also held the position of Principal Scientist from April 2021 to March 2022. Before joining Vesalius Therapeutics, Danijela served as a Principal Scientist at Lucy Therapeutics from October 2020 to April 2021. Danijela has also worked at Proteostasis Therapeutics, Inc. (PTI) where they held various roles including Principal Scientist from February 2020 to August 2020, Senior Scientist Project Lead from January 2016 to August 2020, and Scientist from May 2015 to January 2016. Danijela'searlier work experience includes a role as a Research Specialist II at the Howard Hughes Medical Institute from August 2008 to May 2015, and a Senior Research Associate at Harvard Medical School from May 2004 to August 2008.

Danijela Dukovski holds a Doctor of Philosophy (PhD) degree from the University of Massachusetts Amherst. The specific field of study during their PhD is not provided. In addition to their degree, they have obtained a certification in Leadership for Drug Development Teams from the Tufts Center for the Study of Drug Development in October 2021.